LPS+CS诱导12周建立符合临床标准的COPD小鼠模型

李武; 刘雲华; 石拓; 戴晓天; 邓国宏; 熊玮

doi:10.16016/j.2097-0927.202301084

您当前的位置：

首页 >

文章列表页 >

LPS+CS诱导12周建立符合临床标准的COPD小鼠模型

基础医学 | 更新时间：2026-01-09

- LPS+CS诱导12周建立符合临床标准的COPD小鼠模型
- Establish of a mouse model of COPD that meets clinical criteria by LPS+cigarette smoke exposure for 12 weeks
- 陆军军医大学学报 2023年45卷第9期页码：982-988
- 作者机构：
  
  1.400038 重庆, 陆军军医大学(第三军医大学)第一附属医院: 老年医学与特勤医学科
  2.400038 重庆, 陆军军医大学(第三军医大学)第一附属医院: 感染科
  3.400038 重庆, 陆军军医大学(第三军医大学)第一附属医院: 呼吸内科
- 作者简介：
  
  [熊玮，E-mail：xiongwei64@hotmail.comXIONG Wei, E-mail: xiongwei64@hotmail.com
- 基金信息：
  
  ‍国家重点研发计划(2018YFC2000301)
- DOI：10.16016/j.2097-0927.202301084
  中图分类号： R-332;R363.13;R563.9
- 收稿：2023-01-16，
  
  修回：2023-02-09，
  
  纸质出版：2023-05-15
- 稿件说明：
移动端阅览
李武, 刘雲华, 石拓, 等. LPS+CS诱导12周建立符合临床标准的COPD小鼠模型[J]. 陆军军医大学学报, 2023,45(9):982-988.

Wu LI, Yunhua LIU, Tuo SHI, et al. Establish of a mouse model of COPD that meets clinical criteria by LPS+cigarette smoke exposure for 12 weeks[J]. Journal of Army Medical University, 2023, 45(9): 982-988.
李武, 刘雲华, 石拓, 等. LPS+CS诱导12周建立符合临床标准的COPD小鼠模型[J]. 陆军军医大学学报, 2023,45(9):982-988. DOI： 10.16016/j.2097-0927.202301084.

Wu LI, Yunhua LIU, Tuo SHI, et al. Establish of a mouse model of COPD that meets clinical criteria by LPS+cigarette smoke exposure for 12 weeks[J]. Journal of Army Medical University, 2023, 45(9): 982-988. DOI： 10.16016/j.2097-0927.202301084.

摘要

目的

探究用脂多糖(lipopolysaccharide

LPS)联合香烟烟雾(cigarette smoke

CS)诱导12周可否成功构建符合临床标准的慢性阻塞性肺疾病(chronic obstructive pulmonary disease

COPD)小鼠模型。

方法

选取8周龄雄性C57BL/6小鼠30只

体质量20~25 g

分为模型组和对照组。采用LPS+CS联合诱导进行造模

在第1、14天使用LPS (2 mg

/kg)气管内给药

给药当天不给予CS

其余时间小鼠暴露于CS中吸烟2次/d (10支、60 min/次)。LPS+CS联合诱导12周的小鼠为模型组(

=15)

未进行干预的同批次小鼠为对照组(

=15)。造模后对比两组小鼠肺组织病理(HE、Masson染色)、炎症因子(IFN-γ、IL-12、TNF-α、IL-6)和肺功能(FEV

0.1

/FVC%)的变化。

结果

与对照组相比

LPS+CS诱导后小鼠肺组织病理显示支气管平滑肌层纤维化、肺泡膈断裂、肺泡融合

平均肺泡截距显著增大(

0.05)

平均肺泡数显著减少(

0.05)

全身和肺部促炎炎症因子IFN-γ、IL-12、TNF-α、IL-6均明显增多

肺功能FEV

0.1

/FVC%明显降低(

0.05)

平均肺泡截距和FEV

0.1

/FVC%极其显著负相关(

=-0.922 6

0.001)

而平均肺泡数和FEV

0.1

/FVC%呈极其显著正相关(

=0.933 0

0.001)。

结论

采用LPS+CS诱导12周可以成功建立符合临床标准的COPD小鼠模型。

Abstract

Objective

To investigate whether the induction of lipopolysaccharide (LPS) combined with cigarette smoke (CS) for 12 weeks can successfully construct a mouse model of chronic obstructive pulmonary disease (COPD) that meets clinical criteria.

Methods

Thirty male C57BL/6 mice (8 weeks old

20~25 g) were subjected and randomly divided into model (

=15) and control groups (

=15).A combined induction of LPS+CS was used for modeling

and LPS (2 mg/kg) was administered intratracheally only on days 1 and 14

while CS exposure (2 times/d

10 cigarettes

60 min/time) was conducted on the other days during the induction for 12 weeks.The same batch of mice were given no intervention and served as the control group.Changes in lung histopathology (HE and Masson staining)

inflammatory factor levels (IFN-γ

IL-12

TNF-α and IL-6) and lung function (FEV

0.1

/FVC%) were compared between the 2 groups of mice after modeling.

Results

When compared with the control group

LPS+CS induction resulted in obvious fibrosis of bronchial smooth muscle layer

alveolar diaphragm dissection

alveolar fusion

and significantly increased mean alveolar intercept (

0.001)

obviously decreased mean alveolar number (

0.001)

notably elevated systemic and pulmonary pro-inflammatory factors IFN-γ

IL-12

TNF-α and IL-6 levels

and reduced FEV

0.1

/FVC% value (

0.001).Mean alveolar intercept and FEV

0.1

/FVC% were extremely significantly negatively correlated (

=-0.922 6

0.001)

while mean alveolar number and FEV

0.1

/FVC% had extremely significant positive correlation (

=0.933 0

0.001).

Conclusion

A mouse model of COPD that meets clinical criteria can be established successfully with LPS+CS induction for 12 weeks.

关键词

Keywords

references

CHRISTENSON S A, SMITH B M, BAFADHEL M, et al . Chronic obstructive pulmonary disease[J ] . Lancet, 2022, 399(10342): 2227-2242.

SORIANO J B, POLVERINO F, COSIO B G. What is early COPD and why is it important?[J]. Eur Respir J, 2018, 52(6): 1801448. DOI: 10.1183/13993003.01448-2018.

RABE K F, WATZ H. Chronic obstructive pulmonary disease[J]. Lancet, 2017, 389(10082): 1931-1940. DOI: 10.1016/S0140-6736(17)31222-9.

YOSHIDA M, MINAGAWA S, ARAYA J, et al . Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis[J ] . Nat Commun, 2019, 10(1): 3145. DOI: 10.1038/s41467-019-10991-7.

MOTZ G T, EPPERT B L, WESSELKAMPER S C, et al . Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2 -/- mice[J ] . Am J Respir Crit Care Med, 2010, 181(11): 1223-1233. DOI: 10.1164/rccm.200910-1485OC..

KOBAYASHI S, FUJINAWA R, OTA F, et al . A single dose of lipopolysaccharide into mice with emphysema mimics human chronic obstructive pulmonary disease exacerbation as assessed by micro-computed tomography[J ] . Am J Respir Cell Mol Biol, 2013, 49(6): 971-977. DOI: 10.1165/rcmb.2013-0074OC.

CHEN J L, YANG X, ZHANG W Y, et al . Therapeutic effects of resveratrol in a mouse model of LPS and cigarette smoke-induced COPD[J ] . Inflammation, 2016, 39(6): 1949-1959. DOI: 10.1007/s10753-016-0430-3.

YANG D Q, XU D, WANG T, et al . Mitoquinone ameliorates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice[J ] . Int Immunopharmacol, 2021, 90: 107149. DOI: 10.1016/j.intimp.2020.107149.

KUBO H, ASAI K, KOJIMA K, et al . Astaxanthin suppresses cigarette smoke-induced emphysema through Nrf2 activation in mice[J ] . Mar Drugs, 2019, 17(12): 673. DOI: 10.3390/md17120673.

CHENG Q M, FANG L J, FENG D D, et al . Memantine ameliorates pulmonary inflammation in a mice model of COPD induced by cigarette smoke combined with LPS[J ] . Biomed Pharmacother, 2019, 109: 2005-2013. DOI: 10.1016/j.biopha.2018.11.002.

LEE K M, RENNE R A, HARBO S J, et al . 3-week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice[J ] . Inhal Toxicol, 2007, 19(1): 23-35. DOI: 10.1080/08958370600985784.

WANG L, PELGRIM C E, PERALTA MARZAL L N, et al . Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis[J ] . Am J Physiol Lung Cell Mol Physiol, 2022, 323(3): L266-L280. DOI: 10.1152/ajplung.00486.2021.

SHU J Z, LI D F, OUYANG H P, et al . Comparison and evaluation of two different methods to establish the cigarette smoke exposure mouse model of COPD[J ] . Sci Rep, 2017, 7(1): 15454. DOI: 10.1038/s41598-017-15685-y.

DONG L Y, WANG Y, ZHENG T T, et al . Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice[J ] . Stem Cell Res Ther, 2021, 12(1): 4. DOI: 10.1186/s13287-020-02072-0.

SUZUKI M, IKARI J, ANAZAWA R, et al . PAD4 deficiency improves bleomycin-induced neutrophil extracellular traps and fibrosis in mouse lung[J ] . Am J Respir Cell Mol Biol, 2020, 63(6): 806-818. DOI: 10.1165/rcmb.2019-0433OC.

ZHANG Y P, LI W B, WANG W L, et al . siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats[J ] . Acta Pharmacol Sin, 2012, 33(7): 897-908. DOI: 10.1038/aps.2012.39.

LVTHJE L, RAUPACH T, MICHELS H, et al . Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model[J ] . Respir Res, 2009, 10(1): 7. DOI: 10.1186/1465-9921-10-7.

NAVARRO S, REDDY R, LEE J, et al . Inhaled resveratrol treatments slow ageing-related degenerative changes in mouse lung[J ] . Thorax, 2017, 72(5): 451-459. DOI: 10.1136/thoraxjnl-2016-208964.

WU H, MA H M, WANG L M, et al . Regulation of lung epithelial cell senescence in smoking-induced COPD/emphysema by microR-125a-5p via Sp1 mediation of SIRT1/HIF-1a[J ] . Int J Biol Sci, 2022, 18(2): 661-674. DOI: 10.7150/ijbs.65861..

YANG Y, DI T T, ZHANG Z X, et al . Dynamic evolution of emphysema and airway remodeling in two mouse models of COPD[J ] . BMC Pulm Med, 2021, 21(1): 134. DOI: 10.1186/s12890-021-01456-z.

LEFRANÇAIS E, MALLAVIA B, ZHUO H J, et al . Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury[J ] . JCI Insight, 2018, 3(3): e98178. DOI: 10.1172/jci.insight.98178.

GOEL K , SCHWEITZER K S, SERBAN K A, et al . Pharmacological sphingosine-1 phosphate receptor 1 targeting in cigarette smoke-induced emphysema in mice[J ] . Am J Physiol Lung Cell Mol Physiol, 2022, 322(6): L794-L803. DOI: 10.1152/ajplung.00017.2022.

SERRÉ J, TANJEKO A T, MATHYSSEN C, et al . Enhanced lung inflammatory response in whole-body compared to nose-only cigarette smoke-exposed mice[J ] . Respir Res, 2021, 22(1): 86. DOI: 10.1186/s12931-021-01680-5.

LIM S, LAM D C L, MUTTALIF A R, et al . Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey[J ] . Asia Pac Fam Med, 2015, 14(1): 4. DOI: 10.1186/s12930-015-0020-9.

LÓPEZ-CAMPOS J L, TAN W, SORIANO J B. Global burden of COPD[J]. Respirology, 2016, 21(1): 14-23. DOI: 10.1111/resp.12660.

HALPIN D M G, CRINER G J, PAPI A, et al . Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. the 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease[J ] . Am J Respir Crit Care Med, 2021, 203(1): 24-36. DOI: 10.1164/rccm.202009-3533SO.

TAM A, CHURG A, WRIGHT J L, et al . Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease[J ] . Am J Respir Crit Care Med, 2016, 193(8): 825-834. DOI: 10.1164/rccm.201503-0487OC.

GENSCHMER K R, RUSSELL D W, LAL C, et al . Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung[J ] . Cell, 2019, 176(1/2): 113-126. e15. DOI: 10.1016/j.cell.2018.12.002.

BAARSMA H A, BOS S, MEURS H, et al . Pharmacological inhibition of GSK-3 in a Guinea pig model of LPS-induced pulmonary inflammation: Ⅰ. Effects on lung remodeling and pathology[J ] . Respir Res, 2013, 14(1): 113. DOI: 10.1186/1465-9921-14-113.

BONNARDEL E, PREVEL R, CAMPAGNAC M, et al . Determination of reliable lung function parameters in intubated mice[J ] . Respir Res, 2019, 20(1): 211. DOI: 10.1186/s12931-019-1177-9.

JOSHI R, HEINZ A, FAN Q, et al . Role for Cela1 in postnatal lung remodeling and alpha-1 antitrypsin-deficient emphysema[J ] . Am J Respir Cell Mol Biol, 2018, 59(2): 167-178. DOI: 10.1165/rcmb.2017-0361OC.

ZHANG F B, GUO F F, LIU Y, et al . Shema oral liquid a meliorates the severity of LPS-induced COPD via regulating DNMT1[J ] . Front Pharmacol, 2022, 13: 903593. DOI: 10.3389/fphar.2022.903593..

NOVA Z, SKOVIEROVA H, CALKOVSKA A. Alveolar-capillary membrane-related pulmonary cells as a target in endotoxin-induced acute lung injury[J]. Int J Mol Sci, 2019, 20(4): 831. DOI: 10.3390/ijms20040831.

LU C, ZHANG X M, MA C Y, et al . Nontypeable Haemophilus influenzae DNA stimulates type Ⅰ interferon expression via STING signaling pathway[J ] . Biochim Biophys Acta Mol Cell Res, 2018, 1865(4): 665-673. DOI: 10.1016/j.bbamcr.2018.01.011..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

1990-2021年全球50岁以下慢性阻塞性肺病的疾病负担演变和风险因素及趋势预测

柚皮苷改善脂多糖诱导的小鼠抑郁样行为的作用研究

非侵入式静电场刺激对脂多糖诱导神经认知障碍小鼠的改善作用

新疆墨玉县乡村地区慢性阻塞性肺疾病患病现况及影响因素分析